Detlev Riesner

Detlev Riesner General Information

Description

Dr. Detlev Riesner serves as Member of Supervisory Board at Attyloid. He serves as Advisor at Numaferm. Prof. Riesner was chair holder of Biophysics at the Heinrich-Heine-University in Düsseldorf from 1980 to 2007. Further, he was Dean of the Science Faculty and Vice-President of Research. In 2007 he became a member of the University's Board of Trustees. He worked as a research fellow at Princeton University and held a guest professorship at the Department of Neurology at the University of California, San Francisco. Prof. Riesner is a co-founder of Qiagen N.V., Netherlands, was a member of their Supervisory Board and from 1999 to 2014 their chairman. He was also a member of the supervisory boards of NewLab Bioquality AG, Erkrath, Direvo AG, Köln, and Alantos AG, Heidelberg. Prof. Riesner was a member of the scientific advisory boards of the Friedrich-Löffler-Institute, Isle of Riems, and PrioNet and APRI, both in Canada. He received the Max Planck Research Award for international cooperation and the Federal Cross of Merit (Bundesverdienstkreuz 1. Klasse) from the Federal President of Germany.